110 related articles for article (PubMed ID: 17328880)
1. Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.
Lomholt AF; Frederiksen CB; Christensen IJ; Brünner N; Nielsen HJ
Clin Chim Acta; 2007 May; 380(1-2):128-32. PubMed ID: 17328880
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ
Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer.
Frederiksen C; Lykke J; Christensen IJ; Brünner N; Nielsen HJ
Scand J Clin Lab Invest; 2007; 67(5):545-52. PubMed ID: 17763191
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
Frederiksen C; Lomholt AF; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brünner N; Nielsen HJ
Anticancer Res; 2009 Jan; 29(1):75-81. PubMed ID: 19331135
[TBL] [Abstract][Full Text] [Related]
6. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
Holten-Andersen MN; Christensen IJ; Nielsen HJ; Stephens RW; Jensen V; Nielsen OH; Sørensen S; Overgaard J; Lilja H; Harris A; Murphy G; Brünner N
Clin Cancer Res; 2002 Jan; 8(1):156-64. PubMed ID: 11801553
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
Lipton A; Ali SM; Leitzel K; Demers L; Evans DB; Hamer P; Brown-Shimer S; Pierce K; Carney W
Cancer; 2007 May; 109(10):1933-9. PubMed ID: 17407159
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
[TBL] [Abstract][Full Text] [Related]
10. Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.
Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Rino Y; Masuda M; Imada T
Oncology; 2007; 72(3-4):205-8. PubMed ID: 18160809
[TBL] [Abstract][Full Text] [Related]
11. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection.
Nielsen HJ; Brünner N; Frederiksen C; Lomholt AF; King D; Jørgensen LN; Olsen J; Rahr HB; Thygesen K; Hoyer U; Laurberg S; Christensen IJ; ;
Scand J Gastroenterol; 2008; 43(2):242-8. PubMed ID: 18224568
[No Abstract] [Full Text] [Related]
12. Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study.
Holten-Andersen L; Christensen IJ; Jensen SB; Reibel J; Laurberg S; Nauntofte B; Brünner N; Nielsen HJ
Scand J Gastroenterol; 2012 Oct; 47(10):1234-41. PubMed ID: 22871105
[TBL] [Abstract][Full Text] [Related]
13. [Tissue inhibitor of metalloproteinase-1 (TIMP-1) in colorectal cancer: correlation with clinico-morphological factors].
Korotkova EA; Gershteĭn ES; Prorokov VV; Kushlinskiĭ NE
Vopr Onkol; 2009; 55(2):171-6. PubMed ID: 19514370
[TBL] [Abstract][Full Text] [Related]
14. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
Holten-Andersen MN; Fenger C; Nielsen HJ; Rasmussen AS; Christensen IJ; Brünner N; Kronborg O
Eur J Cancer; 2004 Sep; 40(14):2159-64. PubMed ID: 15341992
[TBL] [Abstract][Full Text] [Related]
15. Impact of elective resection on plasma TIMP-1 levels in patients with colon cancer.
Hammer JH; Basse L; Svendsen MN; Werther K; Brünner N; Christensen IJ; Nielson HJ
Colorectal Dis; 2006 Mar; 8(3):168-72. PubMed ID: 16466554
[TBL] [Abstract][Full Text] [Related]
16. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
[TBL] [Abstract][Full Text] [Related]
17. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment.
Møller Sørensen N; Vejgaard Sørensen I; Ørnbjerg Würtz S; Schrohl AS; Dowell B; Davis G; Jarle Christensen I; Nielsen HJ; Brünner N
Scand J Gastroenterol; 2008; 43(7):774-86. PubMed ID: 18584515
[TBL] [Abstract][Full Text] [Related]
18. Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.
Larsen MB; Stephens RW; Brünner N; Nielsen HJ; Engelholm LH; Christensen IJ; Stetler-Stevenson WG; Høyer-Hansen G
Scand J Immunol; 2005 May; 61(5):449-60. PubMed ID: 15882437
[TBL] [Abstract][Full Text] [Related]
19. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
Mannello F; Jung K; Tonti GA; Canestrari F
Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
[TBL] [Abstract][Full Text] [Related]
20. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.
Holt RI; Erotokritou-Mulligan I; Ridley SA; McHugh CM; Bassett EE; Cowan DA; Bartlett C; Sönksen PH
Growth Horm IGF Res; 2009 Feb; 19(1):43-50. PubMed ID: 18617430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
